1.
Biochemistry
; 56(6): 805-808, 2017 02 14.
Article
in English
| MEDLINE
| ID: mdl-28135072
ABSTRACT
The biosynthesis of the azabicyclic ring system of the azinomycin family of antitumor agents represents the "crown jewel" of the pathway and is a complex process involving at least 14 enzymatic steps. This study reports on the first biosynthetic step, the inroads, in the construction of the novel aziridino [1,2-a]pyrrolidine, azabicyclic core, allowing us to support a new mechanism for azabicycle formation.